Retraction Note: MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ

Arch Pharm Res. 2025 Jan 2. doi: 10.1007/s12272-024-01530-0. Online ahead of print.
No abstract available

Publication types

  • Retraction of Publication